Expert neurologists discuss patient cases involving the treatment of adult-onset spinal muscular atrophy (SMA).
EP. 1: A 28-Year-Old Male With SMA
Arun S. Varadhachary, MD, PhD provides an overview of the case of a 28-year-old male with spinal muscular atrophy, describes the 4 main phenotypes of SMA, and considers how average age of onset impacts patient prognosis.
EP. 2: The Importance of Early Diagnosis of SMA
An expert neurologist, Arun S. Varadhachary, MD, PhD considers the diagnostic process for SMA and emphasizes the importance of early diagnosis to optimize care.
EP. 3: A 38-Year-Old Female with Spinal Muscular Atrophy
James Wymer, MD, provides a case overview of a 38-year-old female diagnosed with spinal muscular atrophy.
EP. 4: Diagnosis of Adult-Onset SMA
An overview of the diagnosis of spinal muscular atrophy, including prevalence, age of onset, and the role of genetic testing.
EP. 5: A Multidisciplinary Approach to Managing SMA
A key opinion leader in neurology highlights the value of a multidisciplinary approach to care for patients with spinal muscular atrophy in order to maximize a patient’s function through physical and medical therapy.
EP. 6: The Safety and Efficacy of Nusinersen for SMA
A specialist in the care of patients with spinal muscular atrophy reviews the CHERISH trial of nusinersen and examines the drug’s safety and efficacy profiles.
EP. 7: Treatment Approach in SMA
A discussion of the multidisciplinary treatment approach in spinal muscular atrophy.
EP. 8: Goals of Therapy and Treatment Selection in Adult-Onset SMA
An insight into the goals of therapy and treatment selection between oral and intrathecal medications for adult-onset spinal muscular atrophy.
EP. 9: Unmet Needs and the Future of SMA Care
Arun S. Varadhachary, MD, PhD shares insights into clinicians’ and patients’ experiences with medical therapy, comments on unmet needs for adult patients, and speculates about the future of SMA care.
EP. 10: Importance of Compliance and Multidisciplinary Management in SMA
An expert neurologist emphasizes the importance of medication compliance and the value of multidisciplinary management in meeting patient goals of therapy for spinal muscular atrophy.
EP. 11: Experience with Risdiplam and Unmet Needs in SMA
James Wymer, MD discusses his firsthand experience with risdiplam and identifies a key unmet need in the treatment of spinal muscular atrophy.
2 Clarke Drive Cranbury, NJ 08512